Lbmc Investment Advisors LLC Has $310,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Lbmc Investment Advisors LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 612 shares of the healthcare conglomerate’s stock after selling 35 shares during the period. Lbmc Investment Advisors LLC’s holdings in UnitedHealth Group were worth $310,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Lone Pine Capital LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at about $480,903,000. Accredited Investors Inc. grew its position in shares of UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares in the last quarter. Raymond James & Associates increased its holdings in UnitedHealth Group by 33.1% during the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after acquiring an additional 587,088 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec boosted its position in shares of UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after acquiring an additional 581,324 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on UNH shares. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH opened at $510.03 on Monday. The firm has a market cap of $469.38 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The stock’s 50 day moving average is $549.37 and its two-hundred day moving average is $563.18. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.